![]()
For the forth quarter 2017 Assembly Biosciences, Inc decreased loss of $
-0.16 per share compare to $
-0.67 a year ago and improved from $
-0.71 per share from the previous quarter.
Sales remained unchanged to $
3 millions from $0 millions in the same quarter a year ago and sequentially Sales improved by 24.66 % from $3 millions.
In the forth quarter 2017 Assembly Biosciences, Inc reported net loss of $
-3 million, instead of deficit of $
-12 millions in the same quarter a year ago.
Assembly Biosciences, Inc reported net loss of $
-43 millions and Sales of $
9 millions for the fiscal year 2017.
Biotechnology & Drugs Company has decreased it's loss per share to
$-2.41 from
$-2.57 in the previous fiscal year, while by 0 % from $0 millions a year ago.
